MedImmune, Inc. v. Genentech, Inc.

Last updated
MedImmune, Inc. v. Genentech, Inc.
Seal of the United States Supreme Court.svg
Argued October 4, 2006
Decided January 9, 2007
Full case nameMedImmune, Inc. v. Genentech, Inc.
Docket no. 05-608
Citations549 U.S. 118 ( more )
127 S. Ct. 764; 166 L. Ed. 2d 604; 2007 U.S. LEXIS 1003; 75 U.S.L.W. 4034; 81 U.S.P.Q.2d 1225
Case history
PriorNo. CV 03-2567, 2004 U.S. Dist. LEXIS 28680 (C.D. Cal. Apr. 26, 2004); affirmed, 427 F.3d 958 (Fed. Cir. 2005); cert. granted, 546 U.S. 1169(2006).
Subsequent535 F. Supp. 2d 1000 (C.D. Cal. 2008)
Holding
Contrary to respondents’ assertion that only a freestanding patent-invalidity claim is at issue, the record establishes that petitioner has raised and preserved the contract claim that, because of patent invalidity, unenforceability, and noninfringement, no royalties are owing. 427 F.3d 958, reversed and remanded.
Court membership
Chief Justice
John Roberts
Associate Justices
John P. Stevens  · Antonin Scalia
Anthony Kennedy  · David Souter
Clarence Thomas  · Ruth Bader Ginsburg
Stephen Breyer  · Samuel Alito
Case opinions
MajorityScalia, joined by Roberts, Stevens, Kennedy, Souter, Ginsburg, Breyer, Alito
DissentThomas

MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007), was a decision by the Supreme Court of the United States involving patent law. [1] It arose from a lawsuit filed by MedImmune which challenged one of the Cabilly patents issued to Genentech. One of the central issues was whether a licensee retained the right to challenge a licensed patent, or whether this right was forfeited upon signing of the license agreement. The case related indirectly to past debate over whether the US should change to a first to file patent system - in 2011, President Obama signed the Leahy-Smith America Invents Act, which shifted the United States to a first-inventor-to-file patent system.

Contents

Background

The origin of the dispute was a lengthy interference proceeding between Genentech and Celltech which led to the issuance of a new patent in 2001, 18 years after the original filing. This effectively granted Genentech a patent term of 29 years. [2] MedImmune was a licensee of the later Cabilly patent, but argued that the term had been improperly extended and that it need not continue to pay royalties past the original expiry date in March 2006. The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech appealed the USPTO the ruling and the patent remained valid and enforceable until the appeal was concluded. Genentech prevailed during the reexamination of Cabilly II(2) by the USPTO (1). GlaxoSmithKline and Human Genome Sciences both are challenging the patent under antitrust law (1). This is based on the settlement between Genentech and Celltech and their dispute over the original Cabilly patent 4,816,567 and the Celltech's patent 4,816,397. Both of which issued on March 28, 1989 (2),(3). Cabilly II is patent 6331415(4) which issued December 18, 2001.

Opinion of the Court

The Court held [1] that:

1 licensee adequately raised and preserved its contract claim;
2 licensee was not required to terminate or breach license agreement prior to seeking declaratory judgment of patent invalidity, abrogating Gen–Probe Inc. v. Vysis, Inc. ; [3] and
3 Supreme Court would not address whether action was subject to dismissal on discretionary grounds.

Reversed and remanded.

Justice Thomas filed a dissenting opinion.

See also

Related Research Articles

As with all utility patents in the United States, a biological patent provides the patent holder with the right to exclude others from making, using, selling, or importing the claimed invention or discovery in biology for a limited period of time - for patents filed after 1998, 20 years from the filing date.

A declaratory judgment, also called a declaration, is the legal determination of a court that resolves legal uncertainty for the litigants. It is a form of legally binding preventive by which a party involved in an actual or possible legal matter can ask a court to conclusively rule on and affirm the rights, duties, or obligations of one or more parties in a civil dispute. The declaratory judgment is generally considered a statutory remedy and not an equitable remedy in the United States, and is thus not subject to equitable requirements, though there are analogies that can be found in the remedies granted by courts of equity. A declaratory judgment does not by itself order any action by a party, or imply damages or an injunction, although it may be accompanied by one or more other remedies.

NTP, Inc. is a Virginia-based patent holding company founded in 1992 by the late inventor Thomas J. Campana Jr. and Donald E. Stout. The company's primary asset is a portfolio of 50 US patents and additional pending US and international patent applications. These patents and patent applications disclose inventions in the fields of wireless email and RF Antenna design. The named inventors include Andrew Andros and Thomas Campana. About half of the US patents were originally assigned to Telefind Corporation, a Florida-based company partly owned by Campana.

Michael Howard Wigler is an American molecular biologist who has directed a laboratory at Cold Spring Harbor Laboratory since 1978 and is a member of the National Academy of Sciences. He is best known for developing methods to genetically engineer animal cells and his contributions to cancer, genomics and autism genetics.

The Cabilly patents are two US patents issued to Genentech and City of Hope which relate to the "fundamental technology required for the artificial synthesis of antibody molecules." The name refers to lead inventor Shmuel Cabilly, who was awarded the patent while working at City of Hope in the 1980s. There was ongoing legal controversy surrounding these patents since their original filing in 1983. In 2008, the litigation that was pending before the U.S. District Court for the Central District of California, was fully resolved and dismissed.

Earnest Lloyd Trammell, is an American inventor in the field of dimensional sound processing. Most known for selling the first working surround sound to Hughes Aircraft and working on the Peavey KOSMOS processors, Lloyd was also featured in an Electronic Musician Magazine article on sound design.

The analytical profile index or API is a classification of bacteria based on biochemical tests, allowing fast identification. This system is developed for quick identification of clinically relevant bacteria. Because of this, only known bacteria can be identified.

Altvater v. Freeman, 319 U.S. 359 (1943), was a decision by the Supreme Court of the United States which held that, although a licensee had maintained payments of royalties, a Declaratory Judgment Act claim of invalidity of the licensed patent still presented a justiciable case or controversy.

The method of screening has been linked to the early Egyptians who used the process to separate basic minerals by using a mesh that had equal openings. This idea fell down through the ages and developed into a series of European patents around 1924, when the thought of electrically heating the wire cloth for screens was considered. This was the first attempt at eliminating screen blinding by using heat, and it proved that the surface tension from blinding was reduced when heat was introduced.

In telecommunication and computer networking, time-driven switching (TDS) is a node by node time variant implementation of circuit switching, where the propagating datagram is shorter in space than the distance between source and destination. With TDS it is no longer necessary to own a complete circuit between source and destination, but only the fraction of circuit where the propagating datagram is temporarily located. TDS adds flexibility and capacity to circuit-switched networks but requires precise synchronization among nodes and propagating datagrams.

Preco Electronics Inc is a multinational vendor of radar-based object detection systems headquartered in Boise, Idaho, United States.

Qarbon is a software company headquartered in San Jose, CA.

<span class="mw-page-title-main">Limbal ring</span> Dark ring around the iris of the eye

A limbal ring is a dark ring around the iris of the eye, where the sclera meets the cornea. It is a dark-colored manifestation of the corneal limbus resulting from optical properties of the region. The appearance and visibility of the limbal ring can be negatively affected by a variety of medical conditions concerning the peripheral cornea. It has been suggested that limbal ring thickness may correlate with health or youthfulness and may contribute to facial attractiveness. Some contact lenses are colored to simulate limbal rings.

<span class="mw-page-title-main">Jean Paoli</span>

Jean Paoli is one of the inventors of XML. Along with Tim Bray and C. Michael Sperberg-McQueen, Paoli co-edited the XML 1.0 recommendation for the World Wide Web Consortium starting in 1997 and until at least 2008.

i4i is an independent software company specializing in the delivery of XML / SGML document processing software in Toronto, Ontario, Canada, founded by Michel Vulpe in 1993.

Convergent encryption, also known as content hash keying, is a cryptosystem that produces identical ciphertext from identical plaintext files. This has applications in cloud computing to remove duplicate files from storage without the provider having access to the encryption keys. The combination of deduplication and convergent encryption was described in a backup system patent filed by Stac Electronics in 1995. This combination has been used by Farsite, Permabit, Freenet, MojoNation, GNUnet, flud, and the Tahoe Least-Authority File Store.

Dwight Marcus was the Chief Technology Officer and one of the co-founders of NPOWR Digital Media. He attended Worcester Polytechnic Institute, where he was a Henry J. Fuller Scholar. Marcus is also the inventor of the stimTV Network, which in 2007 won the Technology and Engineering Emmy Award from the National Academy of Television Arts and Sciences.

Markes International, headquartered in the UK, develops and manufactures scientific instruments for thermal desorption.

Randall Coleman Fowler is an American inventor, entrepreneur, and investor.

The Pee Pocket is a single-use urinary device that allows a person to stand while urinating, in situations where they could not normally do so.

References

  1. 1 2 MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007). PD-icon.svg This article incorporates public domain material from this U.S government document.
  2. Carter, Eugenia G. "IP Licensing and the Supreme Court's Medimmune v. Genentech Decision" (PDF). Wisconsin Intellectual Property Law Association. Retrieved March 22, 2007.[ permanent dead link ]
  3. Gen–Probe Inc. v. Vysis, Inc., 359F.3d1376 (Fed. Cir.2004).

Further reading